Biome Australia (ASX:BIO) filed its inaugural patent application for probiotic strain BMB18, according to a Monday filing with the Australian bourse.
Human clinical trial on the BMB18 strain is expected to be conducted with La Trobe University in the fourth quarter of the year, the filing said.
Shares rose nearly 1% in afternoon trade Monday.
Chifeng Jilong Gold Mining (SHA:600988, HKG:6693) recorded a 104% rise in attributable profit in the first quarter of 2025 to 988.2 million yuan from 483.4 million yuan in the year-ago period, according to a Friday Hong Kong bourse filing.The miner's earnings per share jumped to 0.52 yuan from 0.29 yuan in the corresponding period of the previous fiscal year.Operating income increased 48% to 3.55 billion yuan from 2.41 billion yuan a year prior.The firm attributed the positive performance to the optimization of production organization and operational management, allowing the firm to benefit from a year-over-year rise in goldselling price.
Jiayuan Services (HKG:1153) completed the placing of 60.5 million shares to two investors at HK$0.25 apiece to raise net proceeds of HK$14.6 million, according to a Friday Hong Kong bourse filing.The shares represent approximately 9% of the real estate developer's enlarged issued share capital.The firm will use proceeds for general working capital, as well as for the settlement of outstanding payables.
BOCOM International (HKG:3329) unit Preferred Investment Management acquired $9 million of certain bonds for $9.1 million from the over-the-counter market on Wednesday, according to a Friday Hong Kong bourse filing.The bonds will be issued by Sumitomo Mitsui Trust Bank and listed on the Singapore Exchange.The company purchased the bonds for investment purposes.